Clinical Characteristics as Predictors of Response to Fluvoxamine, Paroxetine and Milnacipran in Patients with Depression

Publisher： Bentham Science Publishers

E-ISSN： 1875-6441|1|3|319-324

ISSN： 1573-4005

Source： Current Psychiatry Reviews, Vol.1, Iss.3, 2005-11, pp. : 319-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender

By Morishita S. Arita S.

European Psychiatry, Vol. 18, Iss. 8, 2003-12 ,pp. : 418-420

Elsevier

Access to resources Recommend Favorite

The clinical use of milnacipran for depression

By Morishita S. Arita S.

European Psychiatry, Vol. 18, Iss. 1, 2003-02 ,pp. : 34-35

Elsevier

Access to resources Recommend Favorite

Milnacipran in the treatment of elderly depressed patients including a case of interferon-induced depression

By Yoshida Keizou

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 1, 2003-01 ,pp. : 19-21

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Glucocorticoids as Predictors of Treatment Response in Depression

By Horstmann Sonja Binder Elisabeth B.

Harvard Review of Psychiatry, Vol. 19, Iss. 3, 2011-06 ,pp. : 125-143

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Genotypes of cytochrome P450 and clinical response to clomipramine in patients with major depression

By Bouchez J. Dumur V. Lhermitte M. Goudemand M.

European Psychiatry, Vol. 10, Iss. 8, 1995-01 ,pp. : 410-412

Elsevier

Access to resources Recommend Favorite